CAPR – capricor therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
Duchenne muscular dystrophy: Five trials to watch [Yahoo! Finance]
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Capricor Therapeutics, Inc. (CAPR) Q4 2024 Earnings Call Transcript [Seeking Alpha]
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Form 10-K CAPRICOR THERAPEUTICS, For: Dec 31
Form 8-K CAPRICOR THERAPEUTICS, For: Mar 19
Form 4 CAPRICOR THERAPEUTICS, For: Mar 03 Filed by: Marban Linda
Form 4 CAPRICOR THERAPEUTICS, For: Mar 03 Filed by: Litvack Frank
Form 4 CAPRICOR THERAPEUTICS, For: Mar 03 Filed by: DUNBAR GEORGE W JR
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.